Piper Sandler Reiterates Overweight on Braze, Raises Price Target to $30

Benzinga Newsdesk www.benzinga.com Positive 71.8%

Neg 0% Neu 0% Pos 71.8%

Piper Sandler analyst Billy Fitzsimmons reiterates Braze (NASDAQ:BRZE) with a Overweight and raises the price target from $27 to $30.